deflazacort has been researched along with Disease Exacerbation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, DA; Darras, BT; Elfring, G; Landry, J; McDonald, CM; McDonnell, E; Peltz, SW; Sajeev, G; Shieh, PB; Signorovitch, J; Souza, M; Yao, Z | 1 |
| Bach, JR; Brahmsteadt, AE; Cespedes, L; Pierucci, P; Pishdad, R | 1 |
| de Carvalho, SC; Marques, MJ; Matsumura, CY; Santo Neto, H | 1 |
| Amaddeo, A; Amin, R; Burrows, C; Darmahkasih, A; Fauroux, B; Gurbani, N; Horn, PS; Khirani, S; Pascoe, J; Rutter, MM; Rybalsky, I; Sawnani, H; Shellenbarger, KC; Simakajornboon, N; Tian, C; Wong, B | 1 |
| Mayer, OH | 1 |
| Campbell, KA; Fox, DJ; Kim, S; Matthews, DJ; Valdez, R | 1 |
| Benson, DW; Fleck, RJ; Gao, Z; Hor, KN; Jefferies, JL; Mazur, W; Sticka, JJ; Tandon, A; Taylor, MD; Towbin, JA; Villa, CR; Wong, BL | 1 |
| Kuntz, NL; Wong-Kisiel, LC | 1 |
| Campbell, K; Ciafaloni, E; Fox, DJ; Moxley, RT; Pandya, S | 1 |
| Carvalho, MS; Marie, SK; Parreira, SL; Reed, UC; Resende, MB; Zanoteli, E | 1 |
| Battini, R; Bello, L; Berardinelli, A; Bertini, E; Bianco, F; Bonfiglio, S; Bruno, C; Cavallaro, F; Comi, G; D'Amico, A; De Sanctis, R; Doglio, L; Donati, MA; Frosini, S; Gasperini, S; Martinelli, D; Mazzone, E; Mercuri, E; Messina, S; Mongini, T; Motta, MC; Napolitano, S; Pane, M; Pegoraro, E; Pini, A; Politano, L; Previtali, S; Rossi, F; Sacco, A; Scutifero, M; Sormani, MP; Torrente, Y; Vasco, G; Vita, G; Zucchini, E | 1 |
| Machado, DL; Reed, UC; Resende, MB; Silva, EC; Silva, RF; Zanoteli, E | 1 |
| Cripe, L; King, E; Kinnett, K; Pratt, J; Sage, J; Spicer, R; Uzark, K; Varni, JW; Wong, B | 1 |
| Alman, BA; Biggar, WD; Raza, SN | 1 |
| Balaban, B; Carry, T; Clayton, GH; Matthews, DJ | 1 |
| De Paula Vernetta, C; García Callejo, FJ; Marco Algarra, J; Morera Pérez, C; Orts, AM; Platero Zamarreño, A; Velert Vila, MM | 1 |
| Comi, LI; De Luca, F; Nigro, G; Palladino, A; Passamano, L; Politano, L | 1 |
3 review(s) available for deflazacort and Disease Exacerbation
| Article | Year |
|---|---|
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials.
Topics: Anti-Inflammatory Agents; Child; Disease Progression; Humans; Male; Multicenter Studies as Topic; Muscular Dystrophy, Duchenne; Prednisolone; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic; Treatment Outcome; Walking | 2020 |
Pulmonary function and clinical correlation in DMD.
Topics: Disease Progression; Glucocorticoids; Humans; Morpholinos; Muscular Dystrophy, Duchenne; Oxadiazoles; Prednisone; Pregnenediones; Respiratory Function Tests; Respiratory Insufficiency | 2019 |
Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.
Topics: Child; Disease Progression; Drug Administration Schedule; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Time Factors; Treatment Outcome | 2010 |
1 trial(s) available for deflazacort and Disease Exacerbation
| Article | Year |
|---|---|
Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.
Topics: Activities of Daily Living; Adolescent; Anti-Inflammatory Agents; Child; Disease Progression; Follow-Up Studies; Humans; Male; Muscle Weakness; Muscular Dystrophy, Duchenne; Predictive Value of Tests; Pregnenediones; Prevalence; Proportional Hazards Models; Risk Factors; Scoliosis; Spinal Fusion; Survival Analysis; Time Factors; Treatment Outcome; Vital Capacity; Walking | 2004 |
13 other study(ies) available for deflazacort and Disease Exacerbation
| Article | Year |
|---|---|
Glucocorticoid-Associated Demise of a Patient With Duchenne Muscular Dystrophy.
Topics: Adult; Anti-Inflammatory Agents; Disease Progression; Drug Administration Schedule; Glucocorticoids; Humans; Long Term Adverse Effects; Male; Muscular Dystrophy, Duchenne; Pregnenediones | 2020 |
Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Disease Progression; Fatty Acids, Omega-3; Interferon-gamma; Interleukins; Mice; Muscular Dystrophy, Duchenne; Pregnenediones; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2018 |
Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naïve Patients with Duchenne Muscular Dystrophy.
Topics: Adolescent; Child; Disease Progression; Glucocorticoids; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Respiratory Function Tests; Retrospective Studies | 2019 |
Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy: Treatment Duration and Time to Loss of Ambulation.
Topics: Adrenal Cortex Hormones; Age of Onset; Child; Disease Progression; Follow-Up Studies; Humans; Longitudinal Studies; Male; Muscular Dystrophy, Duchenne; Neuromuscular Agents; Prednisone; Pregnenediones; Proportional Hazards Models; Time Factors; United States; Walking | 2015 |
Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.
Topics: Adolescent; Adult; Age Factors; Child; Disease Progression; Fibrosis; Glucocorticoids; Heart; Humans; Magnetic Resonance Imaging; Male; Muscular Dystrophy, Duchenne; Myocardium; Prednisone; Pregnenediones; Retrospective Studies; Stroke Volume; Young Adult | 2015 |
Two siblings with limb-girdle muscular dystrophy type 2E responsive to deflazacort.
Topics: Adolescent; Biopsy; Child; Disease Progression; DNA Mutational Analysis; Female; Genotype; Humans; Immunohistochemistry; Immunosuppressive Agents; Male; Muscle Strength; Muscle, Skeletal; Muscular Dystrophies, Limb-Girdle; Pregnenediones; Sarcoglycans; Severity of Illness Index; Siblings; Treatment Outcome | 2010 |
Comparison of motor strength and function in patients with Duchenne muscular dystrophy with or without steroid therapy.
Topics: Age Factors; Anti-Inflammatory Agents; Child; Child, Preschool; Disease Progression; Female; Glucocorticoids; Humans; Male; Motor Activity; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Prednisolone; Pregnenediones | 2010 |
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Disease Progression; Female; Humans; Male; Muscular Dystrophy, Duchenne; Prednisolone; Pregnenediones; Reproducibility of Results; Severity of Illness Index; Statistics as Topic; Walking | 2011 |
Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy.
Topics: Adolescent; Child; Disability Evaluation; Disease Progression; Glucocorticoids; Humans; Motor Activity; Muscular Dystrophy, Duchenne; Prednisolone; Pregnenediones | 2012 |
Health-related quality of life in children and adolescents with Duchenne muscular dystrophy.
Topics: Activities of Daily Living; Adolescent; Age Factors; Anti-Inflammatory Agents; Child; Child, Preschool; Disability Evaluation; Disease Progression; Humans; Male; Muscular Dystrophy, Duchenne; Needs Assessment; Prednisone; Pregnenediones; Quality of Life; Reference Values; Sick Role; Social Adjustment; Surveys and Questionnaires; Wheelchairs | 2012 |
Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.
Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Body Weight; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Glucocorticoids; Humans; Male; Motor Activity; Motor Skills; Muscle Weakness; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; Statistics, Nonparametric | 2005 |
[Blood viscosity profile in rapidly progressive sensorineural hearing loss with positive Western-blot].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Blood Viscosity; Blotting, Western; Disease Progression; Female; Hearing Loss, Sensorineural; Humans; Male; Pregnenediones; Severity of Illness Index | 2006 |
Cardiac treatment in neuro-muscular diseases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Cardiac Output, Low; Case-Control Studies; Disease Progression; Fosinopril; Furosemide; Humans; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Myotonic Dystrophy; Pregnenediones; Prognosis; Retrospective Studies; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors | 2006 |